A New Year report from CPhI forecasts 2018 will be a transformative year for Japanese pharma as the market evolves towards growth in generics, biosimilars and increased internationalization.
The CPhI Japan 2018 report released ahead of what is likely to be the largest ever CPhI JapOriginal Article
